|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | +7.69% |
|
+7.69% | +131.40% |
| Market Cap | 1.55M 1.34M 1.25M 1.15M 2.18M 147M 2.2M 14.76M 5.77M 73.55M 5.81M 5.68M 244M | P/E 2023 |
-25x | P/E 2024 | -5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 1.06M 924K 862K 792K 1.5M 101M 1.51M 10.16M 3.97M 50.62M 4M 3.91M 168M | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.28x |
| Free-Float |
35.53% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +7.69% | ||
| 1 week | +7.69% | ||
| 1 month | +39.30% | ||
| 3 months | +39.30% | ||
| 6 months | +48.94% | ||
| Current year | +131.40% |
| 1 month | 0.17 |  | 0.28 |
| Current year | 0.12 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0 | | 0.34 |
| 5 years | 0 | | 0.64 |
| 10 years | 0 | | 1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justice Anderson
CEO | Chief Executive Officer | 49 | 09/01/2018 |
James Anderson
CEO | Chief Executive Officer | 56 | 22/09/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
Justice Anderson
BRD | Director/Board Member | 49 | 01/01/2006 |
James Anderson
BRD | Director/Board Member | 56 | 01/12/2006 |
Regina Anderson
CHM | Chairman | 79 | 01/09/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/24 A | Other | Director | 12,848 | 0.1585% | ||
| 7/31/24 A | Other | Director | 7,200 | 0.0888% | ||
| 7/31/24 A | Other | Director | 5,600 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.69% | +7.69% | +47.37% | +12.90% | 2.29M | |
| -0.51% | -8.60% | +45.08% | +148.21% | 1T | |
| +0.20% | -4.42% | +49.05% | +50.81% | 613B | |
| -0.53% | -7.37% | +23.64% | +65.03% | 433B | |
| +0.48% | -2.77% | +40.27% | +34.96% | 350B | |
| +0.08% | -4.45% | +31.74% | +39.89% | 292B | |
| +2.09% | -9.27% | +5.42% | +7.61% | 239B | |
| +1.75% | -8.29% | -1.73% | -42.05% | 206B | |
| +2.94% | -0.78% | +29.17% | +60.32% | 204B | |
| +3.13% | +0.69% | +18.11% | +71.90% | 163B | |
| Average | +1.83% | -3.37% | +28.81% | +44.96% | 350.05B | |
| Weighted average by Cap. | +0.72% | -5.59% | +33.88% | +71.02% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.69M 4.07M 3.79M 3.49M 6.59M 446M 6.66M 44.73M 17.49M 223M 17.6M 17.21M 738M | 4.98M 4.33M 4.04M 3.71M 7.01M 474M 7.09M 47.57M 18.6M 237M 18.72M 18.31M 785M |
| Net income | -50.24K -43.63K -40.68K -37.37K -70.67K -4.78M -71.45K -480K -187K -2.39M -189K -185K -7.92M | -341K -296K -276K -254K -480K -32.45M -485K -3.26M -1.27M -16.22M -1.28M -1.25M -53.75M |
| Net Debt | -427K -371K -346K -318K -601K -40.66M -608K -4.08M -1.59M -20.33M -1.61M -1.57M -67.35M | -482K -419K -390K -359K -678K -45.86M -686K -4.6M -1.8M -22.92M -1.81M -1.77M -75.96M |
Employees
20
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- PCYN Stock
Select your edition
All financial news and data tailored to specific country editions
